Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER.

Slides:

Advertisements

Similar presentations

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H

Advertisements

Volume 385, Issue 9986, Pages (June 2015)

Volume 387, Issue 10034, Pages (May 2016)

A Meta-Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement Hisato Takagi, MD, PhD, Masao Niwa, MD, Yusuke Mizuno,

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients Danielle K. Farrington, MD, Patrick D. Kilgo,

Mechanical Versus Bioprosthetic Aortic Valve Replacement in Middle-Aged Adults: A Systematic Review and Meta-Analysis Dong Fang Zhao, BA, Michael Seco,

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

The Association of Transcatheter Aortic Valve Replacement Availability and Hospital Aortic Valve Replacement Volume and Mortality in the United States

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Graft Operation: A PARTNER Trial Subgroup Analysis

Transcatheter and Surgical Aortic Valve Replacement in Dialysis Patients: A Propensity- Matched Comparison Dale M. Kobrin, BA, Fenton H. McCarthy, MD,

Transcatheter Aortic Valve Replacement Results in Improvement of Pulmonary Function in Patients With Severe Aortic Stenosis Richard C. Gilmore, BA, Vinod.

Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS

Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population Christina M. Vassileva,

Emergency use of cardiopulmonary bypass in complicated transcatheter aortic valve replacement: Importance of a heart team approach Eric E. Roselli, MD,

Reply The Annals of Thoracic Surgery

A comprehensive review of the PARTNER trial

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

Predicted Risk of Mortality, Transfusion, and Postoperative Outcomes in Isolated Primary Valve Operations W. Brent Keeling, MD, Jose Binongo, PhD, Eric.

Lily E. Johnston, MD, MPH, Emily A. Downs, MD, Robert B

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Theron A. Paugh, CCP, Timothy A. Dickinson, MS, James R

Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation Don Hayes, MD, MS, Stephen Kirkby,

Transatlantic editorial on transcatheter aortic valve replacement

Impact of Preoperative Renal Dysfunction on Long-Term Survival for Patients Undergoing Aortic Valve Replacement Vinod H. Thourani, MD, W. Brent Keeling,

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Harm H. H. Feringa, MD, Leslee J

The Impact of Specific Preoperative Organ Dysfunction in Patients Undergoing Aortic Valve Replacement Vinod H. Thourani, MD, Ritam Chowdhury, MD, Rebecca.

Should We Perform Carotid Doppler Screening Before Surgical or Transcatheter Aortic Valve Replacement? Jose F. Condado, MD, MS, Hanna A. Jensen, MD,

Transcatheter Aortic Valve Replacement Has Improved Short-Term but Similar Midterm Outcomes in Isolated Aortic Valve Replacement After Prior Coronary.

The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons.

Impact of Left Ventricular Systolic Function on Outcome of Correction of Chronic Severe Aortic Valve Regurgitation: Implications for Timing of Surgical.

Matthew L. Williams, MD, Joseph E. Bavaria, MD, Michael A

Gorav Ailawadi, MD, Damien J. LaPar, MD, MS, Alan M. Speir, MD, Ravi K

Factors Affecting Survival After Mitral Valve Replacement in Patients With Prosthesis– Patient Mismatch Abdulhameed Aziz, MD, Jennifer S. Lawton, MD,

Transapical Aortic Valve Replacement for Severe Aortic Stenosis: Results From the Nonrandomized Continued Access Cohort of the PARTNER Trial Todd M.

Use of Transaortic, Transapical, and Transcarotid Transcatheter Aortic Valve Replacement in Inoperable Patients Vinod H. Thourani, MD, Rebecca L. Gunter,

Minimalist transcatheter aortic valve replacement: The new standard for surgeons and cardiologists using transfemoral access? Hanna A. Jensen, MD, PhD,

The Progression of a Transcatheter Aortic Valve Program: A Decision Analysis of More Than 680 Patient Referrals Joseph E. Bavaria, MD, Wilson Y. Szeto,

Outcomes of Treatment of Nonagenarians With Severe Aortic Stenosis

The “Double-Valve” Sign in Acute Type A Aortic Dissection

Pulmonary Function Tests Overestimate Chronic Pulmonary Disease in Patients With Severe Aortic Stenosis Mitchell J. Magee, MD, Morley A. Herbert, PhD,

Use of Amiodarone After Major Lung Resection

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Transcatheter Aortic Valve Replacement Outcomes in Nonagenarians Stratified by Transfemoral and Transapical Approach Christian McNeely, MD, Alan Zajarias,

Impact of Transcatheter Technology on Surgical Aortic Valve Replacement Volume, Outcomes, and Cost Robert B. Hawkins, MD, Emily A. Downs, MD, Lily E.

Vinod H. Thourani, MD, Hanna A

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

A Meta-Analysis of Minimally Invasive Versus Conventional Sternotomy for Aortic Valve Replacement Kevin Phan, BS(Adv), Ashleigh Xie, Marco Di Eusanio,

Transcatheter aortic valve replacement in intermediate-risk patients

Michele Gallo, MD, Gino Gerosa, MD

Transcatheter Aortic Valve Replacement: How I Teach It

Good at One or Good at All

Percutaneous Transcatheter Closure of the Aortic Valve

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Takashi Murashita, MD, Kevin L. Greason, MD, Rakesh M

Vinod H. Thourani, MD, Hanna A

The Association of Chronic Lung Disease With Early Mortality and Respiratory Adverse Events After Aortic Valve Replacement Juan A. Crestanello, MD, Robert.

Aortic and Mitral Valve Replacement Versus Transcatheter Aortic Valve Replacement in Propensity-Matched Patients Fenton H. McCarthy, MD, Nimesh D. Desai,

Mechanical Versus Bioprosthetic Aortic Valve Replacement in Middle-Aged Adults: A Systematic Review and Meta-Analysis Dong Fang Zhao, BA, Michael Seco,

Outcomes of Patients With Severe Chronic Lung Disease Who Are Undergoing Transcatheter Aortic Valve Replacement Rakesh M. Suri, MD, DPhil, Brian C. Gulack,

The Association of Transcatheter Aortic Valve Replacement Availability and Hospital Aortic Valve Replacement Volume and Mortality in the United States

Kreton Mavromatis, MD, Vinod H

Transcatheter Aortic Valve Replacement Versus Aortic Valve Bypass

United States Feasibility Study of Transcatheter Insertion of a Stented Aortic Valve by the Left Ventricular Apex Lars G. Svensson, MD, PhD, Todd Dewey,

The Annals of Thoracic Surgery

Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society.

Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H

Racing to the Rubicon Michael J. Reardon, MD, Vinod H. Thourani, MD

Experience With Bovine Pericardium for the Reconstruction of the Aortic Arch in Patients Undergoing a Norwood Procedure Victor O. Morell, MD, Peter A.

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Presentation transcript:

Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial Vinod H. Thourani, MD, Jessica Forcillo, MD, MS, Nirat Beohar, MD, Darshan Doshi, MD, Rupa Parvataneni, MS, Girma M. Ayele, MD, Ajay J. Kirtane, MD, Vasilis Babaliaros, MD, Susheel Kodali, MD, Chandan Devireddy, MD, Wilson Szeto, MD, Howard C. Herrmann, MD, Raj Makkar, MD, Gorav Ailawadi, MD, Scott Lim, MD, Hersh S. Maniar, MD, Alan Zajarias, MD, Rakesh Suri, MD, E. Murat Tuzcu, MD, Samir Kapadia, MD, Lars Svensson, MD, PhD, Jose Condado, MD, Hanna A. Jensen, MD, PhD, Michael J. Mack, MD, Martin B. Leon, MD The Annals of Thoracic Surgery Volume 102, Issue 4, Pages 1172-1180 (October 2016) DOI: 10.1016/j.athoracsur.2016.07.001 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 One-year all-cause mortality Placement of Aortic Transcatheter Valves (PARTNER) 1 cohorts A and B: transcatheter aortic valve replacement (TAVR) only. (CI = confidence interval; GFR = glomerular function rate; HR = hazard ratio.) The Annals of Thoracic Surgery 2016 102, 1172-1180DOI: (10.1016/j.athoracsur.2016.07.001) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 One-year all-cause mortality Placement of Aortic Transcatheter Valves (PARTNER) 1 cohort A: transcatheter aortic valve replacement (TAVR) only. (CI = confidence interval; GFR = glomerular function rate; HR = hazard ratio.) The Annals of Thoracic Surgery 2016 102, 1172-1180DOI: (10.1016/j.athoracsur.2016.07.001) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 One-year all-cause mortality Placement of Aortic Transcatheter Valves (PARTNER) 1 cohort B: transcatheter aortic valve replacement (TAVR) only. (CI = confidence interval; GFR = glomerular function rate; HR = hazard ratio.) The Annals of Thoracic Surgery 2016 102, 1172-1180DOI: (10.1016/j.athoracsur.2016.07.001) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions